Pharmafile Logo

Wilmington Healthcare appoints new Solutions Director

May 27, 2021 | NHS, Promotion, healthcare 

Kirsty Fryer has been promoted to the role of Solutions Director for Wilmington Healthcare

Wilmington Healthcare, a market leader in the provision of data, insight and intelligence for pharma and medtech companies, has announced the promotion of Kirsty Fryer to the role of Solutions Director.

In her new role, Kirsty will be responsible for the Quantis portfolio of products offered by Wilmington Healthcare, leading the team as they continue to deliver outstanding service and solutions to the organisation’s customers. Bringing together all disciplines, from analytical, development, commercial and marketing to underpin Wilmington Healthcare’s ambitious growth plans, Kirsty will ensure customers continue to receive trusted insight and real-world data solutions.

Kirsty steps up to the role having been Solutions Consultant since November 2017 and a valued member of the Wilmington Healthcare team since 2015. In this time, she has developed her career from bespoke researcher supporting the organisation’s understanding of the healthcare ecosystem before joining the solutions team working with real-world evidence – transforming data-led insight into core messages and potential implications. With a PhD in Neurophysiology from the University of Nottingham and currently undertaking an MBA with senior leadership focus she brings a wealth of expertise to the role alongside her existing client relationships.

Welcoming the appointment Jonathan Carney, of Wilmington Healthcare, says: “Kirsty has been a huge asset to Wilmington Healthcare since she joined the company in 2015. Her promotion to lead one of our key growth products in the role of Solutions Director is recognition for her passion, energy and commitment in delivering the very best for our customers combined with her extensive knowledge of our products and the impact they help to make in shaping sustainable commercial and partnership strategies for our customers. Through Kirsty’s appointment we will be building upon our market credentials as a trusted, leading organisation in the Healthcare Insight arena.”

Kirsty Fryer adds: ‘I’m proud of my work over the last five years within Wilmington Healthcare and I’m excited to guide our fantastic team as we continue to provide bespoke, real-world insight to meet the individual needs of our customers in parallel with the evolving needs of the NHS in this new era of healthcare impacted by the COVID-19 pandemic.”

This content was provided by Wilmington Healthcare

Company Details

 Latest Content from  Wilmington Healthcare 

Wilmington Healthcare launches new platform to map the formulary landscape

Healthcare intelligence provider Wilmington Healthcare has launched a new platform that enables pharma companies to develop a clear picture of formulary status across therapy areas and territories in the UK.

Wilmington Healthcare appoints new Head of Digital

Wilmington Healthcare, which provides data, insight and intelligence for pharma and medtech companies, has appointed Pfizer’s former UK Digital Marketing Manager, Mikko Figura, as Head of Digital.In his new role,...

How has the pandemic reshaped the NHS in 2020?

Oli Hudson, of Wilmington Healthcare, explores the major changes that have occurred across the NHS as key aspects of the Long Term Plan are rolled out at speed.

Harness the power of data to map new patient pathways

Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset

How can pharma align its brand strategy with the NHS Reset?

Oli Hudson, of Wilmington Healthcare, explores how pharma should respond to plans to ‘reboot’ the NHS during the covid recovery era

Covid-19 redefines rules of customer engagement

Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs

White paper helps industry navigate new NHS roadmap

New report shows how pharma can support the NHS in the Covid-19 recovery era

Covid-19 drives change in long-term conditions management

Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home

Covid-19: how is it impacting on the NHS Long-term Plan?

Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the plan but put others in jeopardy

Covid-19: what could it mean for the diabetic population?

Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it